Central nervous system toxicity attributable to epidural ropivacaine hydrochloride

Anaesthesia and Intensive Care

Volumn 26, Issue 2, 1998, Pages 204-206

  Plowman, A N ^a   Bolsin, S ^b   Mather, L E ^b  

^a GEELONG HOSPITAL   (Australia)

^b NONE

Author keywords

Anaesthetics, local, epidural: ropivacaine, toxicity; Brain: central nervous system, toxicity, ropivacaine

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; ROPIVACAINE;

ADOLESCENT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CONVULSION; EPIDURAL ANESTHESIA; EPIDURAL DRUG ADMINISTRATION; HUMAN; MALE; NEUROTOXICITY;

EID: 0031920958     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9802600214     Document Type: Article

References (10)

1. Turner G, Blake D, Buckland M, et al. Continuous extradural infusion of ropivacaine for prevention of postoperative pain after major orthopaedic surgery. Br J Anaesth 1996; 76:606-610.
2. Scott DA, Chamley DM, Mooney PH, Deam RK, Mark AH, Haselof B. Epidural ropivacaine infusion for postoperative analgesia after major lower abdominal surgery - a dose finding study. Anesth Analg 1995; 81:982-986.
3. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563-569.
4. Feldman HS, Arthur GR, Pitkanen M, Hurley R, Doucette AM, Covino BG. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991; 73:373-384.
5. Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69:794-801.
6. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg 1989; 69:276-283.
7. Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology 1991; 74:639-642.
8. Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg 1989; 69:736-738.
9. Australian Prescription Products Guide. 25 ed. Australian Pharmaceutical Publishing Company 1996; 661.
10. Mather LE, Bjorkman S. Pitfalls in pharmacokinetics. Anaesthetic Pharmacology Review 1994; 2:260-270.